Navigation Links
NeuroDerm Announces Positive Results of a Phase II Study of ND0611 Dermal Patch in Patients with Parkinson's Disease
Date:11/9/2011

NESS ZIONA, Israel, November 9, 2011 /PRNewswire/ --

NeuroDerm, Ltd. announced today the results of a Phase I/II safety and pharmacokinetic trial of ND0611, administered as an adjunct therapy to Sinemet®, Sinemet® CR or Stalevo®, in patients with advanced Parkinson's disease. ND0611 is a proprietary carbidopa liquid formula administered sub-cutaneously via a dermal patch to increase the bioavailability and efficacy of orally- administered levodopa. Results of this study support the continued development of ND0611 for the treatment of Parkinson's disease.

This double-blind, randomized, six-way crossover study met all of its primary and secondary endpoints. The analysis showed that ND0611, when compared with placebo, showed meaningful, highly statistically significant improvement in all of the pharmacokinetic (PK) endpoints when administered with three most common oral levodopa therapies (immediate-release Sinemet®,  Sinemet®-CR, and Stalevo®). The primary and secondary PK endpoints included levodopa half-life, the duration of levodopa concentration in excess of a threshold of 1000ng/ml in plasma, the area-under-the-concentration-time-curve and levodopa trough levels. The full results of this study will be presented at a future scientific meeting.

The most common adverse events across all treatment arms, including placebo, were vertigo, nausea, asthenia, back pain, myalgia, pain in extremity, headache and erythema. There were no clinically relevant effects seen in laboratory measured or vital signs.

"This first trial in patients of ND0611 hit all of its endpoints and was a complete success. ND0611 is an innovative treatment for PD and this important milestone justifies ND0611's further clinical and regulatory development," said Sheila Oren, MD, VP Clinical and Regulatory Affairs at NeuroDerm.

'/>"/>
SOURCE NeuroDerm Ltd
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. NeuroDerm Initiates Phase 2 Study of ND0801 in Patients with ADD/ADHD
2. NeuroDerm Successfully Completes Enrollment and Dosing in a Phase 1 Clinical Study of ND0611 Dermal Patch for Parkinsons Disease
3. China Sky One Medical Announces Third Quarter 2011 Results
4. China Information Technology, Inc. Announces Third Quarter 2011 Results
5. Uroplasty Announces Issuance of New Apparatus Patent for the Urgent® PC Neuromodulation System Stimulator
6. Micell Technologies Announces Positive Preliminary Data from DESSOLVE I Study of MiStent® Sirolimus Drug Eluting Coronary Stent System
7. K-V Pharmaceutical Announces Updated Makena® Performance Metrics
8. MedBox Announces Ticker Symbol Change
9. SMT Research & Development, Ltd. Names Shuki Porath as Vice President and General Manager, Announces TCT Presence
10. ECRI Institute Announces its Top 10 Health Technology Hazards for 2012
11. Echo Therapeutics Announces Third Quarter 2011 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21, 2013 Kepner-Tregoe (KT), the ... that 13-year veteran Chris Geraghty ... experience includes more than 20 years serving the ... manufacturing organizations. He succeeds Ray Baxter ... Kepner-Tregoe,s Chairman of the Board and CEO. ...
(Date:5/21/2013)... , May 21, 2013  IsoRay, Inc. (AMEX: ... it has entered into an exclusive international distribution agreement ... product line in Greece . IsoRay ... brachytherapy and medical radioisotope applications for brain cancer, lung ... ("gyn") cancer. IASIS Medical is ideally ...
(Date:5/21/2013)... , May 21, 2013  Vasomedical, Inc. (OTC BB: VASO) ... design, manufacture and sale of medical devices and in the ... Jun Ma , President and CEO of ... MicroCap Conference on Thursday, May 30, 2013 in ... The Company,s presentation is scheduled to begin ...
Breaking Medicine Technology:Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 2Kepner-Tregoe, Inc. Promotes Chris Geraghty to Chief Executive Officer 3IsoRay Announces A New International Distributor For Greece 2IsoRay Announces A New International Distributor For Greece 3Vasomedical, Inc. To Present At The Second Annual Marcum LLP MicroCap Conference 2
... N.Y., Sept. 9 Misonix, Inc. (Nasdaq: ... the art, ultrasonic medical device technology, which worldwide ... into a new, three year, exclusive distribution agreement ... will sell and distribute the SonaStar® Ultrasonic Surgical ...
... video detailing has made a strong comeback after ... and healthcare market research company Manhattan Research,s ... detailing has more than doubled in the past two years, ... self-report that their prescribing behavior is influenced by these programs, ...
Cached Medicine Technology:Misonix Announces New Distribution Agreement For Spain 2Misonix Announces New Distribution Agreement For Spain 3New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting 2New Study: Physician Adoption of Live Video Detailing Has Doubled Since 2008, But Will Likely Plateau Until 2012 as Pharma Optimizes Targeting 3
(Date:5/21/2013)... Adeptia, a leading provider of innovative ... it is the featured company in an impact report ... report, “Adeptia Bets on Converged Cloud Integration and Process-Orchestration ... strategy, products, pricing, customers and competition. , ... for integration and process orchestration, especially when price, ease ...
(Date:5/21/2013)... May 21 (HealthDay News) -- Urban elementary school ... experience sleep problems and suffer academically, new research ... aged seven to nine, we found that compromised ... and impaired academic performance," said study author ... human behavior at Brown University,s Alpert Medical School ...
(Date:5/21/2013)... 21 (HealthDay News) -- The monstrous tornado that ... adults and children, is a stunning example of ... well-being. But even thunderstorms with lightning and ... experts note. Some anxiety in the ... children develop storm phobias that interfere with their ...
(Date:5/21/2013)... Philosophical Society (APS) has awarded New York University neuroscientist ... in recognition of his "pioneering work on the neuroscience ... University,s Center for Neural Science, is the second NYU ... yearsJoseph LeDoux received the honor in 2011 in recognition ... emotional learning, particularly fear learning, and fear memory." ...
(Date:5/21/2013)... 2013 Residents in St. Petersburg, FL ... now that Dr. David Sherberg, DMD, has joined Coast ... Dr. Sherberg provides preventive, restorative and cosmetic dentistry to ... friendly team provide a wide variety of services ... canal therapy, crowns, bridges, dentures, dental implant restorations, veneers, ...
Breaking Medicine News(10 mins):Health News:Adeptia Featured in Recent 451 Research Impact Report 2Health News:Sleepless Nights May Hurt School Performance of Kids With Asthma 2Health News:Weather Worries Can Threaten a Child's Mental Health 2Health News:NYU's Movshon receives Lashley Award for his research on the neuroscience of vision 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 2Health News:Coast Dental Pasadena Welcomes Dr. David Sherberg 3
... - Telephone outreach can dramatically increase the incidence of ... population, constituting predominantly of black men and women. ... not believe in getting regular CRC screening done. ... day stool blood test, reduces mortality by as much ...
... could reduce 50% of the HIV infection rate among heterosexual ... Ugandan men seeking it.// , ,2,500 Ugandan ... of which nearly half were adults. Less than 400 adult ... Health found that new HIV infections among circumcised heterosexual men ...
... University of Vermont have uncovered the possible causes for ... Their findings were// published November 1, 2006 in the ... is responsible for signaling regional blood flow changes in ... receive an uninterrupted supply of oxygen and glucose, which ...
... "picture-to-speech" project in Singapore is using a customised ... lives of the intellectually disabled,// innovators said Thursday. ... the handheld innovation helps those with speech impairments ... ordering food or asking for medical attention from ...
... chronic hepatitis C are at risk of suffering from ... two weeks from commencement of treatment, says the researchers in ... Visual Science (IOVS)in the January 2007 issue. ,Researchers ... changes in diameter of blood vessels and the velocity ...
... will now have to prescribe medicines by their generic names ... Singh. ,"We have issued a letter in this regard ... health centres and dispensaries," Singh told IANS. ... salt, and not the brand names. Failure to do so ...
Cached Medicine News:Health News:Telephone Outreach Boost CRC Screening In Urban Minority 2Health News:Potential Key to Brain Blood-Flow Disorders Explored by Scientists 2Health News:Potential Key to Brain Blood-Flow Disorders Explored by Scientists 3Health News:Potential Key to Brain Blood-Flow Disorders Explored by Scientists 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: